Add to ORKGA large body of evidence emerging from pharmacological and knockout studies suggests the involvement of the delta opioid peptide (DOP) receptor in the control of anxiety and depression
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP)...
Knockout and pharmacological studies have shown that delta opioid peptide (DOP) receptor signalling ...
Knockout and pharmacological studies have shown that delta opioid peptide (DOP) receptor signalling...
Knockout and pharmacological studies have shown that delta opioid peptide (DOP) receptor signalling ...
Background and purpose:delta-Opioid receptors (DOP receptors) could represent a novel target in the ...
BACKGROUND AND PURPOSE: Delta-opioid receptors (DOP receptors) could represent a novel target in the...
BACKGROUND AND PURPOSE: Delta-opioid receptors (DOP receptors) could represent a novel target in the...
Treatment-resistant major depressive disorder remains inadequately treated with currently available ...
Treatment-resistant major depressive disorder remains inadequately treated with currently available ...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP) ...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP) ...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP) ...
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP)...
Knockout and pharmacological studies have shown that delta opioid peptide (DOP) receptor signalling ...
Knockout and pharmacological studies have shown that delta opioid peptide (DOP) receptor signalling...
Knockout and pharmacological studies have shown that delta opioid peptide (DOP) receptor signalling ...
Background and purpose:delta-Opioid receptors (DOP receptors) could represent a novel target in the ...
BACKGROUND AND PURPOSE: Delta-opioid receptors (DOP receptors) could represent a novel target in the...
BACKGROUND AND PURPOSE: Delta-opioid receptors (DOP receptors) could represent a novel target in the...
Treatment-resistant major depressive disorder remains inadequately treated with currently available ...
Treatment-resistant major depressive disorder remains inadequately treated with currently available ...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP) ...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP) ...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP) ...
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Systemically active, nonpeptidic delta opioid receptor agonists have been shown to produce antidepre...
Knockout and pharmacological studies demonstrated that the activation of delta opioid peptide (DOP)...